ProfileGDS5678 / 1444298_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 62% 62% 62% 61% 61% 63% 61% 62% 62% 62% 62% 62% 62% 62% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.7696362
GSM967853U87-EV human glioblastoma xenograft - Control 23.7196562
GSM967854U87-EV human glioblastoma xenograft - Control 33.7122562
GSM967855U87-EV human glioblastoma xenograft - Control 43.5828161
GSM967856U87-EV human glioblastoma xenograft - Control 53.6190561
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.8448363
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.7205161
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.6963162
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.6772462
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.6974662
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.7258262
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.6941562
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.7041162
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.7100262